Cesca Therapeutics Snags Bullish HC Wainwright Initiation On CAR-T Opportunity – Benzinga
Benzinga |
Cesca Therapeutics Snags Bullish HC Wainwright Initiation On CAR–T Opportunity
Benzinga CAR–T-cell therapy is a method of treating cancer by using a patient's immune system cells — T cells — which are then modified by adding a gene in the lab for a special chimeric antigen receptor, or CAR, to attack cancer cells. CAR binds to a certain … |
